Cargando…
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals
Autores principales: | Marjani, Majid, Tabarsi, Payam, Moniri, Afshin, Hashemian, Seyed Mohammadreza, Nadji, Seyed Alireza, Abtahian, Zahra, Malekmohammad, Majid, Kiani, Arda, Farzanegan, Behrooz, Eslaminejad, Alireza, Fakharian, Atefeh, Heshmatnia, Jalal, Abedini, Atefeh, Seifi, Sharareh, Yassari, Fatemeh, Mirenayat, Maryam Sadat, Rezaei, Mitra, Sheikhzade, Hakimeh, Ahmadi, Zargham Hossein, Dastan, Farzaneh, Sadeghi, Mohsen, Lookzadeh, Somayeh, Porabdollah, Mihan, Askari, Elham, Baghaei, Parvaneh, Mansourafshar, Babak, Jahangirifard, Alireza, Vasheghani, Maryam, Mokhber Dezfuli, Mojtaba, Varahram, Mohammad, Jamaati, Hamidreza, Mansouri, Davood, Zali, Alireza, Velayati, Ali Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680524/ https://www.ncbi.nlm.nih.gov/pubmed/33262795 |
Ejemplares similares
-
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022) -
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
por: Baghaei, Parvaneh, et al.
Publicado: (2020) -
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form
por: Tabarsi, Payam, et al.
Publicado: (2021) -
Uncommon Complications of Lung Transplantation in a Referral Center
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022) -
Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)